Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Pfizer vaccine

Pfizer Awaits FDA Nod For Omicron-retooled Booster In Kids Under 5

The bivalent COVID-19 vaccine, which targets the original strain and the BA.4/BA.5 Omicron subvariants, is currently authorized as a booster dose for ages 5 years and older in the United States and the European Union (EU)

Read More

Pfizer Covid Vaccine Price Hike To give Revenue Push In Coming Years

The drugmaker, which developed and sells the vaccine with Germany's BioNTech said on Thursday evening that it is targeting a range of $110 to $130 a dose for the vaccine once the United States moves to a commercial market next year

Read More

Pfizer-BioNTech & AstraZeneca Vaccines Give High Protection Against Severe Covid Up To 6 Months: Study

The study found that the rates of Covid hospitalisation and deaths were substantially lower among vaccinated individuals than unvaccinated adults up to six months after the inoculation of the second dose

Read More

U.S FDA Sets June Meeting For Moderna, Pfizer Small Children COVID-vaccines

The June 14 meeting will consider Moderna's emergency use authorization request for youth aged six to 17 years, the FDA said.White House COVID-19 response coordinator Dr. Ashish Jha said on Sunday he expects a U.S. Food and Drug Administration decision on authorizing Moderna's vaccine for children under age five within the next few weeks

Read More

We Will Soon Rollout Our Own Vaccine In Israel, Says Boaz Lev, Head Of Israel Vaccine Task Force

Israel has managed to successfully control the Covid-19 pandemic, whereas India is battling a second wave of the pandemic. Mutations of the virus have perplexed the scientists in the country and raised concern over the efficacy of vaccine against Covid. Israel’s story is important for their approach. Dr. Boaz Lev, Israel’s head of Advisory Committee for Corona Vaccines and Epidemic Control and former Director General of its Administration of Health, in an exclusive interaction with BW Businessworld’s Manish Kumar Jha, talks about his country’s approach and it managed overcome the issues surrounding the pandemic. Excerpts:

Read More

Pfizer Wants To Make Vaccine In India If Faster Clearance, Export Freedom Assured

The Serum Institute of India, the world's largest vaccine maker, is already bulk-manufacturing the Oxford University/AstraZeneca product and plans to start producing the Novavax Inc shot from next month.

Read More

Single dose of Pfizer Covid-19 vaccine may protect against asymptomatic infection: Study

Single dose of Pfizer Covid-19 vaccine may protect against asymptomatic infection: Study

Read More

Israel to inoculate 100,000 Palestinian workers

Israel to inoculate 100,000 Palestinian workers

Read More

UK researchers suggest 1 dose of Pfizer vaccine not enough to kill S African COVID strain

UK researchers suggest 1 dose of Pfizer vaccine not enough to kill S African COVID strain

Read More

WHO issues Emergency Use Validation for Pfizer, BioNTech COVID-19 vaccine

WHO issues Emergency Use Validation for Pfizer, BioNTech COVID-19 vaccine

Read More

90-Year-Old Margaret Keenan From UK Becomes 1st-Person To Receive Pfizer Covid-19 Vaccine

Huge Step forward against Covid-19 as the UK became the first country to get the vaccine before the United States or the European Union.

Read More

Oil Gains As OPEC+ Resumes Output Cut Extension Talks After Impasse

Brent crude was up 21 cents, or 0.4%, at $48.46 a barrel by 0802 GMT, after gaining 1.8% on Wednesday. U.S. oil was 11 cents, or 0.2%, higher at $45.39 a barrel, having ended 1.6% higher the previous session.

Read More

When And How Will COVID-19 Vaccines Become Available?

If regulators approve any of the vaccines in coming weeks, the companies have said distribution could begin almost immediately with governments around the world to decide who gets them and in what order. The following is an outline of the process:

Read More

What does COVID-19 vaccine effectiveness mean?

Two vaccine makers have said that preliminary results from their late-stage studies suggest their experimental vaccines are strongly protective. Moderna this week said its vaccine appears nearly 95 per cent effective.

Read More

Keeping Pfizer's COVID-19 vaccine at low temperatures will be challenging for India, others: AIIMS Director

Keeping Pfizer's COVID-19 vaccine at low temperatures will be challenging for India, others: AIIMS Director

Read More